| UniProt ID | GP1BA_HUMAN | |
|---|---|---|
| UniProt AC | P07359 | |
| Protein Name | Platelet glycoprotein Ib alpha chain | |
| Gene Name | GP1BA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 652 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.. | |
| Protein Sequence | MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDTEGDKVRATRTVVKFPTKAHTTPWGLFYSWSTASLDSQMPSSLHPTQESTKEQTTFPPRWTPNFTLHMESITFSKTPKSTTEPTPSPTTSEPVPEPAPNMTTLEPTPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTPIPTIATSPTILVSATSLITPKSTFLTTTKPVSLLESTKKTIPELDQPPKLRGVLQGHLESSRNDPFLHPDFCCLLPLGFYVLGLFWLLFASVVLILLLSWVGHVKPQALDSGQGAALTTATQTTHLELQRGRQVTVPRAWLLFLRGSLPTFRSSLFLWVRPNGRVGPLVAGRRPSALSQGRGQDLLSTVSIRYSGHSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 37 | N-linked_Glycosylation | EVNCDKRNLTALPPD EECCCCCCCCCCCCC | 47.70 | 16263699 | |
| 37 | N-linked_Glycosylation | EVNCDKRNLTALPPD EECCCCCCCCCCCCC | 47.70 | 16263699 | |
| 129 | Phosphorylation | DVSFNRLTSLPLGAL ECCCCCCCCCCHHHH | 25.61 | - | |
| 130 | Phosphorylation | VSFNRLTSLPLGALR CCCCCCCCCCHHHHH | 32.36 | - | |
| 163 | Phosphorylation | PPGLLTPTPKLEKLS CCCCCCCCCCHHHHH | 28.02 | 18776048 | |
| 175 | N-linked_Glycosylation | KLSLANNNLTELPAG HHHCCCCCCCCCCHH | 48.42 | 3497398 | |
| 267 | Phosphorylation | ASVQCDNSDKFPVYK EEEECCCCCCCCCCC | 29.00 | 22210691 | |
| 292 | Sulfation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | 12087105 | |
| 292 | Sulfation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | - | |
| 292 | Phosphorylation | DEGDTDLYDYYPEED CCCCCCHHHCCCCCC | 12.52 | 18088087 | |
| 294 | Sulfation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | 12087105 | |
| 294 | Sulfation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | - | |
| 294 | Phosphorylation | GDTDLYDYYPEEDTE CCCCHHHCCCCCCCC | 13.83 | 18088087 | |
| 295 | Sulfation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | - | |
| 295 | Sulfation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | 12087105 | |
| 295 | Phosphorylation | DTDLYDYYPEEDTEG CCCHHHCCCCCCCCC | 10.98 | 18088087 | |
| 304 | Acetylation | EEDTEGDKVRATRTV CCCCCCCEEEEEEEE | 44.47 | 20167786 | |
| 308 | O-linked_Glycosylation | EGDKVRATRTVVKFP CCCEEEEEEEEEECC | 19.13 | UniProtKB CARBOHYD | |
| 353 | Phosphorylation | QESTKEQTTFPPRWT CCCCCCCCCCCCCCC | 31.34 | 27174698 | |
| 354 | Phosphorylation | ESTKEQTTFPPRWTP CCCCCCCCCCCCCCC | 33.56 | 27174698 | |
| 360 | Phosphorylation | TTFPPRWTPNFTLHM CCCCCCCCCCEEEEE | 15.05 | 29759185 | |
| 364 | O-linked_Glycosylation | PRWTPNFTLHMESIT CCCCCCEEEEEEEEE | 23.53 | OGP | |
| 476 | Phosphorylation | TSLITPKSTFLTTTK CCCCCCCCCCCCCCC | 42.55 | 29759185 | |
| 477 | Phosphorylation | SLITPKSTFLTTTKP CCCCCCCCCCCCCCC | 58.46 | 29759185 | |
| 494 | O-linked_Glycosylation | LLESTKKTIPELDQP HHHHHCCCCCCCCCC | 12.49 | OGP | |
| 589 | Phosphorylation | LQRGRQVTVPRAWLL ECCCCCCCCCHHHHH | 37.70 | 24719451 | |
| 601 | Phosphorylation | WLLFLRGSLPTFRSS HHHHHHCCCCCCCCE | 28.71 | 28060719 | |
| 603 | Phosphorylation | LFLRGSLPTFRSSLF HHHHCCCCCCCCEEE | 39.78 | 18088087 | |
| 604 | Phosphorylation | FLRGSLPTFRSSLFL HHHCCCCCCCCEEEE | 17.57 | 28270605 | |
| 606 | Phosphorylation | RGSLPTFRSSLFLWV HCCCCCCCCEEEEEE | 30.24 | 18088087 | |
| 607 | Phosphorylation | GSLPTFRSSLFLWVR CCCCCCCCEEEEEEC | 46.59 | 24719451 | |
| 608 | Phosphorylation | SLPTFRSSLFLWVRP CCCCCCCEEEEEECC | 32.10 | 28270605 | |
| 625 | Phosphorylation | RVGPLVAGRRPSALS CCCCCCCCCCCCHHH | 39.02 | 10559231 | |
| 629 | Phosphorylation | LVAGRRPSALSQGRG CCCCCCCCHHHCCCC | 23401153 | ||
| 632 | Phosphorylation | GRRPSALSQGRGQDL CCCCCHHHCCCCCCH | 23401153 | ||
| 641 | Phosphorylation | GRGQDLLSTVSIRYS CCCCCHHHEEEEEEC | 28060719 | ||
| 642 | Phosphorylation | RGQDLLSTVSIRYSG CCCCHHHEEEEEECC | 28060719 | ||
| 644 | Phosphorylation | QDLLSTVSIRYSGHS CCHHHEEEEEECCCC | 29970186 | ||
| 647 | Phosphorylation | LSTVSIRYSGHSL-- HHEEEEEECCCCC-- | 28270605 | ||
| 648 | Phosphorylation | STVSIRYSGHSL--- HEEEEEECCCCC--- | 28270605 | ||
| 651 | Phosphorylation | SIRYSGHSL------ EEEECCCCC------ | 10559231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GP1BA_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GP1BA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| VWF_HUMAN | VWF | physical | 12183630 | |
| FA12_HUMAN | F12 | physical | 10801853 | |
| 1433Z_HUMAN | YWHAZ | physical | 9454760 | |
| 1433Z_HUMAN | YWHAZ | physical | 8631758 | |
| FLNA_HUMAN | FLNA | physical | 11700320 | |
| LYAM3_HUMAN | SELP | physical | 10499919 | |
| FLNB_HUMAN | FLNB | physical | 9651345 | |
| FLNA_HUMAN | FLNA | physical | 25241761 | |
| FA12_HUMAN | F12 | physical | 25241761 | |
| GPIX_HUMAN | GP9 | physical | 12693941 | |
| GP1BB_HUMAN | GP1BB | physical | 12693941 | |
| 1433Z_HUMAN | YWHAZ | physical | 22754302 | |
| VWF_HUMAN | VWF | physical | 2690940 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 258660 | Non-arteritic anterior ischemic optic neuropathy (NAION) | |||||
| 231200 | Bernard-Soulier syndrome (BSS) | |||||
| 153670 | Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) | |||||
| 177820 | Pseudo-von Willebrand disease (VWDP) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach."; Lewandrowski U., Moebius J., Walter U., Sickmann A.; Mol. Cell. Proteomics 5:226-233(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-37, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; TYR-294; TYR-295;SER-603 AND SER-606, AND MASS SPECTROMETRY. | |
| Sulfation | |
| Reference | PubMed |
| "Crystal structure of the platelet glycoprotein Ibalpha N-terminaldomain reveals an unmasking mechanism for receptor activation."; Uff S., Clemetson J.M., Harrison T., Clemetson K.J., Emsley J.; J. Biol. Chem. 277:35657-35663(2002). Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 17-304, AND SULFATION ATTYR-292; TYR-294 AND TYR-295. | |